Monday, February 20, 2017 8:23:48 PM
Not ideal but reasonable. >>
Jbog: you know more about this topic than I but I find it hard to believe that this would be possible. The FDA has leverage because and only because they can withhold approval of a drug with high profit potential, and they lose all of it if they allow what you are suggesting to happen.
I find it unlikely this matter is resolved in < 6 months (with the potential to be much longer) and that is why I won't be a buyer on Tuesday unless it bottoms out in the 12's, which I would be shocked to see (but I do expect a 15-20% drop).
PS- your new supportive, calming persona freaks me out. I liked you better when you played the a-hole
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM